Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Gilead acquires hypertension drug assets from Navitas
Under the terms of the agreement, Gilead will pay Navitas an upfront payment and contingent payments on future net sales. Navitas also could earn additional payments based upon
Under the terms of the agreement, Gilead will pay Navitas an upfront payment and contingent payments on future net sales. Navitas also could earn additional payments based upon
Phospholipid nanosomes are nanometer-sized vesicles of phospholipid bilayers comprised of single or multiple lipid bilayers. As such, they are said to be non-toxic, non-antigenic and biodegradable in character
The submission is based on outcomes of clinical trials in chronic osteoarthritis pain of the knee and chronic low back pain, in addition to data from previously completed
Calypte Life Sciences offers a broad range of recombinant proteins and antigens as well as proprietary reagents, buffers, and other specialty products to researchers and institutions seeking to
Mr Hasler joined Biogen in 2001 from Wyeth Pharmaceuticals where he worked for eight years, serving since 1998 as senior vice president, head of global strategic marketing. Mr
Natus will receive net proceeds from the offering, including the sale of the over-allotment shares, of approximately $84.3 million before expenses. At the completion of the offering Natus
This international Phase III study is evaluating the efficacy, safety and tolerability of prophylactic use of maribavir administered orally for up to 12 weeks for the prevention of
According to the company, the human albumin 12.5g/vial (25%, 50ml), contains the highest concentration and delivers the highest dosage of the human albumin family products in Mainland China,
The application for marketing authorization is supported by an extensive clinical development program consisting of three identical Phase III studies and by data derived from a comprehensive clinical
The plasma profiles after administration to nine subjects demonstrate that the formulation meets the study objectives relative to area under the curve (AUC), maximum concentration (Cmax), and time-to-peak